TURQOZ Drug Patent Profile
✉ Email this page to a colleague
When do Turqoz patents expire, and what generic alternatives are available?
Turqoz is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in TURQOZ is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for TURQOZ
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TURQOZ at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TURQOZ
US Patents and Regulatory Information for TURQOZ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | TURQOZ | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 202980-001 | Jul 31, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |